NSI Equity Snapshot

GLENMARK Weekly Equity Report

Glenmark Pharmaceuticals Limited

Interactive chart JSON snapshot
Latest Close 2,174 INR 12 Jun 2026
1W Return 0.4% latest completed week
4W Return -6.5% short-term follow-through
12W Return -0.3% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides branded, OTC, and generic formulations in the therapeutic areas of dermatology, respiratory, oncology, immunology, pain management, hypertension, central nervous system, cardiology, diabetes, contraceptives, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, and respiratory-metered dose inhaler, dry powder inhaler, and nasal sprays. Its product pipeline includes ISB 2001, a CD38 x BCMA x CD3 TREAT …

Snapshot

What the weekly tape is saying

GLENMARK closed the latest completed week at 2,174 INR. The 4-week return is -6.5% and the 12-week return is -0.3%. Trend Signal is active, Market Dynamics is 0.11. Setup signature: Balanced read with a 58/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 3.0%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 90 Persistence of active Trend Signal over the last year and current streak.
Momentum 35 Blend of 4-week and 12-week follow-through.
Dynamics 44 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 80 Relative leadership and short-term RS change.
Volume 38 Participation compared with the 13-week volume baseline.
Risk Control 62 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
2,111 INR
Vs Trend Line
3.0%
Fair Value
1,473 INR
Vs Fair Value
47.6%
52W High
2,474 INR
52W Low
1,621 INR
Drawdown
-12.1%
Range Position
64.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.4%
4W -6.5%
12W -0.3%
26W 10.1%
52W 30.5%

Trend read

Active Streak
16 weeks
52W Active Weeks
43
52W Active Breadth
82.7%
Sector Scope
IN Healthcare
Sector Rank
87 of 161
Sector Percentile
46.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.11
4W MD Change
-94.1%
Relative Strength
11.49
4W RS Change
-49.8%
Expectation
Positive
Probability
59.95%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
3.0M
13W Average
3.4M
52W Average
4.0M
Vs 13W
0.9x
Vs 52W
0.8x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.8%
52W Volatility
4.1%
Upside Weeks
28
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
3.4% / -2.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NSI
Country
IN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
INR
Market Cap
642.0B

Opportunity signals

  • Trend Signal is active with a 16-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • No major top-level risk cluster is currently dominant.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 2,174 INR 0.4% 2,111 INR 1,473 INR 0.11 11.49 3.0M On
5 Jun 2026 2,166 INR -4.8% 2,102 INR 1,463 INR 0.75 12.97 5.4M On
29 May 2026 2,275 INR 0.7% 2,090 INR 1,453 INR 1.25 18.54 3.2M On
22 May 2026 2,259 INR -2.9% 2,077 INR 1,443 INR 1.64 17.92 4.2M On
15 May 2026 2,326 INR -1.7% 2,062 INR 1,432 INR 1.83 22.91 3.8M On
8 May 2026 2,366 INR -1.7% 2,047 INR 1,421 INR 1.72 23.50 3.6M On
1 May 2026 2,406 INR 4.6% 2,033 INR 1,410 INR 1.45 27.75 3.4M On
24 Apr 2026 2,300 INR 2.2% 2,018 INR 1,398 INR 1.02 23.93 3.5M On
17 Apr 2026 2,250 INR 4.0% 2,007 INR 1,387 INR 0.85 20.15 2.1M On
10 Apr 2026 2,163 INR 3.4% 2,002 INR 1,376 INR 0.92 18.07 2.8M On
3 Apr 2026 2,092 INR -3.6% 2,001 INR 1,365 INR 1.17 21.81 3.2M On
27 Mar 2026 2,170 INR -0.4% 1,999 INR 1,354 INR 1.26 26.66 2.1M On
20 Mar 2026 2,180 INR 0.4% 1,991 INR 1,344 INR 1.24 26.56 3.2M On
13 Mar 2026 2,171 INR 2.2% 1,983 INR 1,332 INR 0.95 26.79 4.3M On